Chemistry:ADB-5'Br-BUTINACA
From HandWiki
Short description: Chemical compound
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C18H25BrN4O2 |
| Molar mass | 409.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug,[1] first detected in Philadelphia in the US in May 2022,[2] and subsequently found in South Korea,[3] Portugal and Sweden.[4] It is specifically listed as an illegal drug in Italy,[5] South Korea[6] and several states in the US,[7][8] and controlled under analogue legislation in various other jurisdictions.
See also
References
- ↑ "In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs". Drug Testing and Analysis. October 2023. doi:10.1002/dta.3592. PMID 37903509.
- ↑ "ADB-5'Br-BINACA". CFSRE Chemistry Report. The Center for Forensic Science Research & Education. https://www.cfsre.org/images/monographs/ADB-5Br-BINACA-055622-CFSRE-Chemistry-Report.pdf.
- ↑ "Comprehensive evaluation of drug cases in Seoul and its metropolitan areas - 2022". Forensic Science International 353: 111877. November 2023. doi:10.1016/j.forsciint.2023.111877. PMID 37989071.
- ↑ "Yttrande enligt 13 § Lag (2011:111) om förstörande av vissa hälsofarliga missbrukssubstanser" (in sv). The Public Health Authority. https://www.folkhalsomyndigheten.se/contentassets/23593f19f3e84792bc4a823f8240894c/adb-5-br-butinaca-adb-b-5br-inaca-03178-2023.pdf.
- ↑ "Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella Tabella I di nuove sostanze psicoattive. (23A01072)" (in it). Italy: Ministry of Health. 13 February 2023. https://www.gazzettaufficiale.it/atto/vediMenuHTML?atto.dataPubblicazioneGazzetta=2023-02-23&atto.codiceRedazionale=23A01072&tipoSerie=serie_generale&tipoVigenza=originario.
- ↑ "˝에이디비-5'비알-부티나카˝ 등 3종 임시마약류 지정예고" (in Korean). Korean Food and Drug Daily News. http://kfdn.co.kr/57854.
- ↑ "18VAC110-20-322. Placement of chemicals in Schedule I.". Administrative Code. Commonwealth of Virginia. https://law.lis.virginia.gov/admincode/title18/agency110/chapter20/section322/.
- ↑ "Section 19-03.1-05 - Schedule I, N.D. Cent. Code § 19-03.1-05". North Dakota Century Code. https://casetext.com/statute/north-dakota-century-code/title-19-foods-drugs-oils-and-compounds/chapter-19-031-uniform-controlled-substances-act/section-19-031-05-schedule-i.
 |  |
